Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Sugar sweetened beverage intake among children and youths shows alarming increases worldwide

Written by | 15 Aug 2024

Children and adolescents (ages 3-19) worldwide consumed on average 23% more sugar sweetened beverages (SSBs) in 2018 than they did in 1990, researchers reported on August 7, 2024… read more.

Study uncovers connections between obesity and heart failure

Written by | 12 Aug 2024

A new small study led by Johns Hopkins Medicine researchers and published July 25th in the journal Nature Cardiovascular Research has revealed the impact of obesity on muscle structure in patients having a… read more.

Exploding popularity of Ozempic and Wegovy among privately insured patients may worsen disparities

Written by | 5 Aug 2024

A new USC study suggests that publicly insured individuals who are most likely to benefit from new drugs for diabetes and obesity are less likely to get them than those with… read more.

Data shows surge in in new GLP-1RA prescriptions for obesity without type 2 diabetes

Written by | 25 Jul 2024

A nationwide study found a marked increase in new GLP-1RA prescriptions over the last decade, particularly since 2020. Semaglutide was the most prescribed GLP-1RA, by far, in 2023…. read more.

Risk of nonarteritic anterior ischemic optic neuropathy (NAION) in patients prescribed semaglutide – Novo Nordisk

Written by | 12 Jul 2024

A new observational study reported for the first time a potential link between Novo Nordisk’s GLP-1 drugs Ozempic and Wegovy and an eye condition that can cause vision… read more.

Genetic study points to oxytocin as possible treatment for obesity and postnatal depression

Written by | 9 Jul 2024

Scientists have identified a gene which, when missing or impaired, can cause obesity, behavioural problems and, in mothers, postnatal depression. The discovery, reported today in Cell, may have wider… read more.

Wegovy (semaglutide) is approved by NMPA (China) for long-term weight management for overweight and obese people – Novo Nordisk

Written by | 30 Jun 2024

Novo Nordisk’s weight-loss drug Wegovy has been approved for sale in China, opening the door to a huge market in which obesity rates have more than doubled among… read more.

Bariatric surgery more effective and durable than new obesity drugs and lifestyle intervention

Written by | 21 Jun 2024

Systematic reviews* of medical literature between 2020 to 2024 show bariatric surgery, also known as metabolic or weight-loss surgery, produces the greatest and most sustained weight loss compared… read more.

Specialist weight-loss services in England unable to keep up with spiralling demand

Written by | 20 Jun 2024

One in six integrated care boards (ICBs) in England have stopped accepting new patients for specialist weight management services as their referral numbers spiral out of control, an… read more.

Price sensitivity to unhealthy foods

Written by | 14 Jun 2024

Consumer data shows people with obesity are more price-sensitive than others when it comes to buying unhealthy foods, suggesting a food tax could be an effective public health… read more.

Intermittent fasting shows promise in improving gut health, weight management

Written by | 6 Jun 2024

A new study by researchers from Arizona State University and their colleagues highlights a dietary strategy for significant health improvement and weight management. Participants following an intermittent fasting… read more.

Adding obesity experts to primary care clinics improves patients’ weight loss outcomes

Written by | 24 May 2024

Giving high-risk patients access to an obesity specialist through their regular primary care clinic increased their chances of receiving at least one evidence-based weight-management treatment, and led to… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.